Literature DB >> 20610593

Bone mineral density in pseudohypoparathyroidism type 1a.

Dominique N Long1, Michael A Levine, Emily L Germain-Lee.   

Abstract

CONTEXT: The biochemical hallmark of pseudohypoparathyroidism type 1a (PHP1a) is resistance to PTH, but based on tissue-specific imprinting of GNAS, PTH resistance may be limited to the renal cortex. Some studies have shown that bone is responsive to PTH, suggesting that PHP1a patients with chronically elevated PTH levels may have low bone mineral density (BMD).
SETTING: This observational study was conducted at the Institute of Clinical and Translational Research, Johns Hopkins Medical Institutions.
SUBJECTS: Twenty-two children and adults with PHP1a were studied. MAIN OUTCOME MEASURE: The main outcome measure was BMD Z-score at the lumbar spine (LS), total hip, femoral neck, and total body using dual-energy x-ray absorptiometry, relative to height, weight, and pubertal status.
RESULTS: The mean (+/-SD) Z-score for height was 0.77 +/- 1.66 and 1.85 +/- 1.15 for BMI. The BMD Z-score at each of the four sites studied was as follows: LS, 0.29 +/- 1.08; total hip, 0.27 +/- 1.24; femoral neck, 0.02 +/- 1.26; and total body, 0.98 +/- 1.50. Only two subjects (9%) had BMD Z-scores less than -2, and each had additional risk factors for low BMD. BMD in total body and LS spine corrected for height-for-age Z-score was significantly greater than normal. There was no correlation between PTH level and BMD Z-score or between body mass index and BMD Z-score.
CONCLUSIONS: Despite secondary hyperparathyroidism, region-specific BMD is not reduced in patients with PHP1a, and total body BMD is significantly greater than normal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610593      PMCID: PMC2936057          DOI: 10.1210/jc.2010-0498

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  60 in total

Review 1.  The anabolic effects of parathyroid hormone.

Authors:  M R Rubin; F Cosman; R Lindsay; J P Bilezikian
Journal:  Osteoporos Int       Date:  2002       Impact factor: 4.507

2.  Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.

Authors:  E S Siris; P D Miller; E Barrett-Connor; K G Faulkner; L E Wehren; T A Abbott; M L Berger; A C Santora; L M Sherwood
Journal:  JAMA       Date:  2001-12-12       Impact factor: 56.272

3.  Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly.

Authors:  B E Hayward; A Barlier; M Korbonits; A B Grossman; P Jacquet; A Enjalbert; D T Bonthron
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

4.  Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia.

Authors:  Eileen M Shore; Jaimo Ahn; Suzanne Jan de Beur; Ming Li; Meiqi Xu; R J McKinlay Gardner; Michael A Zasloff; Michael P Whyte; Michael A Levine; Frederick S Kaplan
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

5.  Serial changes in bone mineral density and bone turnover after correction of secondary hyperparathyroidism in a patient with pseudohypoparathyroidism type Ib.

Authors:  S R Tollin; S Perlmutter; J F Aloia
Journal:  J Bone Miner Res       Date:  2000-07       Impact factor: 6.741

6.  Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms.

Authors:  Giles S H Yeo; Emma J Lank; I Sadaf Farooqi; Julia Keogh; Benjamin G Challis; Stephen O'Rahilly
Journal:  Hum Mol Genet       Date:  2003-03-01       Impact factor: 6.150

7.  Adjusting bone mass for differences in projected bone area and other confounding variables: an allometric perspective.

Authors:  Alan M Nevill; Roger L Holder; Nicola Maffulli; Jack C Y Cheng; Sophie S S F Leung; Warren T K Lee; Joseph T F Lau
Journal:  J Bone Miner Res       Date:  2002-04       Impact factor: 6.741

8.  Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a.

Authors:  Emily L Germain-Lee; Chang Lin Ding; Zhichao Deng; Janet L Crane; Motoyasu Saji; Matthew D Ringel; Michael A Levine
Journal:  Biochem Biophys Res Commun       Date:  2002-08-09       Impact factor: 3.575

9.  Therapy of hypoparathyroidism with intact parathyroid hormone.

Authors:  M R Rubin; J Sliney; D J McMahon; S J Silverberg; J P Bilezikian
Journal:  Osteoporos Int       Date:  2010-01-22       Impact factor: 4.507

10.  The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads.

Authors:  Giovanna Mantovani; Emilia Ballare; Enza Giammona; Paolo Beck-Peccoz; Anna Spada
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

View more
  10 in total

1.  Osteosclerosis in two brothers with autosomal dominant pseudohypoparathyroidism type 1b: bone histomorphometric analysis.

Authors:  Anne Marie Sbrocchi; Frank Rauch; Margaret L Lawson; Stasia Hadjiyannakis; Sarah Lawrence; Murat Bastepe; Harald Jüppner; Leanne Marie Ward
Journal:  Eur J Endocrinol       Date:  2010-11-09       Impact factor: 6.664

Review 2.  Aberrant Bone Regulation in Albright Hereditary Osteodystrophy dueto Gnas Inactivation: Mechanisms and Translational Implications.

Authors:  Patrick McMullan; Emily L Germain-Lee
Journal:  Curr Osteoporos Rep       Date:  2022-02-28       Impact factor: 5.096

3.  A unique case of bilateral triceps avulsion fracture in a patient with pseudohypoparathyroidism.

Authors:  Ali-Asgar Najefi; Peter Domos
Journal:  Shoulder Elbow       Date:  2019-09-25

Review 4.  An update on the clinical and molecular characteristics of pseudohypoparathyroidism.

Authors:  Michael A Levine
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-12       Impact factor: 3.243

5.  Prevalence of Nephrocalcinosis in Pseudohypoparathyroidism: Is Screening Necessary?

Authors:  David W Hansen; Todd D Nebesio; Linda A DiMeglio; Erica A Eugster; Erik A Imel
Journal:  J Pediatr       Date:  2018-04-23       Impact factor: 4.406

6.  Genetic and epigenetic alterations in the GNAS locus and clinical consequences in Pseudohypoparathyroidism: Italian common healthcare pathways adoption.

Authors:  L de Sanctis; F Giachero; G Mantovani; G Weber; M Salerno; G I Baroncelli; M F Elli; P Matarazzo; M Wasniewska; L Mazzanti; G Scirè; D Tessaris
Journal:  Ital J Pediatr       Date:  2016-11-21       Impact factor: 2.638

Review 7.  Management of pseudohypoparathyroidism.

Authors:  Emily L Germain-Lee
Journal:  Curr Opin Pediatr       Date:  2019-08       Impact factor: 2.856

8.  Parental Origin of Gsα Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary Osteodystrophy.

Authors:  Patrick McMullan; Peter Maye; Qingfen Yang; David W Rowe; Emily L Germain-Lee
Journal:  JBMR Plus       Date:  2021-11-16

Review 9.  Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients.

Authors:  Giovanna Mantovani; Murat Bastepe; David Monk; Luisa de Sanctis; Susanne Thiele; S Faisal Ahmed; Roberto Bufo; Timothée Choplin; Gianpaolo De Filippo; Guillemette Devernois; Thomas Eggermann; Francesca M Elli; Aurora Garcia Ramirez; Emily L Germain-Lee; Lionel Groussin; Neveen A T Hamdy; Patrick Hanna; Olaf Hiort; Harald Jüppner; Peter Kamenický; Nina Knight; Elvire Le Norcy; Beatriz Lecumberri; Michael A Levine; Outi Mäkitie; Regina Martin; Gabriel Ángel Martos-Moreno; Manasori Minagawa; Philip Murray; Arrate Pereda; Robert Pignolo; Lars Rejnmark; Rebeca Rodado; Anya Rothenbuhler; Vrinda Saraff; Ashley H Shoemaker; Eileen M Shore; Caroline Silve; Serap Turan; Philip Woods; M Carola Zillikens; Guiomar Perez de Nanclares; Agnès Linglart
Journal:  Horm Res Paediatr       Date:  2020-08-05       Impact factor: 2.852

Review 10.  Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.

Authors:  Giovanna Mantovani; Murat Bastepe; David Monk; Luisa de Sanctis; Susanne Thiele; Alessia Usardi; S Faisal Ahmed; Roberto Bufo; Timothée Choplin; Gianpaolo De Filippo; Guillemette Devernois; Thomas Eggermann; Francesca M Elli; Kathleen Freson; Aurora García Ramirez; Emily L Germain-Lee; Lionel Groussin; Neveen Hamdy; Patrick Hanna; Olaf Hiort; Harald Jüppner; Peter Kamenický; Nina Knight; Marie-Laure Kottler; Elvire Le Norcy; Beatriz Lecumberri; Michael A Levine; Outi Mäkitie; Regina Martin; Gabriel Ángel Martos-Moreno; Masanori Minagawa; Philip Murray; Arrate Pereda; Robert Pignolo; Lars Rejnmark; Rebecca Rodado; Anya Rothenbuhler; Vrinda Saraff; Ashley H Shoemaker; Eileen M Shore; Caroline Silve; Serap Turan; Philip Woods; M Carola Zillikens; Guiomar Perez de Nanclares; Agnès Linglart
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.